Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) EPS (Weighted Average and Diluted): 2022-2024

Historic EPS (Weighted Average and Diluted) for Biofrontera (BFRI) over the last 3 years, with Dec 2024 value amounting to -$3.22.

  • Biofrontera's EPS (Weighted Average and Diluted) rose 36.73% to -$0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.49, marking a year-over-year decrease of 332.81%. This contributed to the annual value of -$3.22 for FY2024, which is 75.27% up from last year.
  • According to the latest figures from FY2024, Biofrontera's EPS (Weighted Average and Diluted) is -$3.22, which was up 75.27% from -$13.02 recorded in FY2023.
  • In the past 5 years, Biofrontera's EPS (Weighted Average and Diluted) registered a high of -$0.61 during FY2022, and its lowest value of -$13.02 during FY2023.
  • Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$3.22 (2024), whereas its average is -$5.62.
  • In the last 5 years, Biofrontera's EPS (Weighted Average and Diluted) plummeted by 2,034.43% in 2023 and then surged by 75.27% in 2024.
  • Yearly analysis of 3 years shows Biofrontera's EPS (Weighted Average and Diluted) stood at -$0.61 in 2022, then crashed by 2,034.43% to -$13.02 in 2023, then surged by 75.27% to -$3.22 in 2024.